SLC5A7

gene product
CHT1, hCHT
This gene encodes a sodium ion- and chloride ion-dependent high-affinity transporter that mediates choline uptake for acetylcholine synthesis in cholinergic neurons. The protein transports choline from the extracellular space into presynaptic terminals for synthesis into acetylcholine. Increased choline uptake results from increased density of this protein in synaptosomal plasma membranes in response to depolarization of cholinergic terminals. Dysfunction of cholinergic signaling has been implicated in various disorders including depression, attention-deficit disorder, and schizophrenia. An allelic variant of this gene is associated with autosomal dominant distal hereditary motor neuronopathy type VIIA. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
78 antibodies from 20 providers.

Antibody properties

General

Applications

or Cancel
AntibodyRefsTypeWBELICCIPIHCFC
antibodies-online
22 antibodies
Novus Biologicals
3 antibodies
NovoPro Bioscience Inc.
2 antibodies
OriGene
4 antibodies
Biorbyt
5 antibodies
Proteintech Group
1 antibody
Abnova Corporation
2 antibodies
Acris Antibodies GmbH
2 antibodies
LifeSpan BioSciences, Inc.
13 antibodies
GeneTex
2 antibodies
Abgent
1 antibody
Invitrogen Antibodies
2 antibodies
Creative Biolabs
7 antibodies
Aviva Systems Biology
1 antibody
MyBioSource
3 antibodies
Abiocode, Inc.
1 antibody
Boster Biological Technology
1 antibody
Creative Diagnostics
3 antibodies
EMD Millipore
2 antibodies
Sigma-Aldrich
1 antibody